TRDA - Entrada Therapeutics, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-1.32
|
Rev Est: $7.4M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$18.00
DETAILS
HIGH:
$21.00
LOW:
$13.00
MEDIAN:
$20.00
CONSENSUS:
$18.00
UPSIDE:
56.79%
Market Cap:
438.76M
Volume:
140,222
Avg Volume:
208,540
52 Week Range:
4.93-13.82
Sector:
Healthcare
Industry:
Biotechnology
Beta:
-0.12
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
183
IPO Date:
2021-10-29
EPS (TTM):
1.76
P/E Ratio:
9.83
Revenue (TTM):
210.78M
Total Assets:
526.32M
Total Debt:
59.21M
Cash & Equiv:
101.21M
Rev Growth (5Y):
63.4%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
9.7%
Debt/Equity:
0.14
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $-1.06 | $-1.04 | -1.9% | $1.6M | $8.5M | -81.0% |
| 2025-08-06 | $-1.04 | $-0.86 | -20.9% | $1.9M | $7.8M | -75.1% |
| 2025-05-08 | $-0.42 | $-0.78 | +46.2% | $20.6M | $9.8M | +110.4% |
| 2025-02-27 | $0.03 | $-0.66 | +104.5% | $37.4M | $13.1M | +185.0% |
| 2024-11-05 | $-0.35 | $-0.67 | +47.8% | $19.6M | $12.9M | +51.4% |
| 2024-08-13 | $1.55 | $0.14 | +1007.1% | $94.7M | $12.3M | +668.6% |
| 2024-05-07 | $0.68 | $-0.59 | +215.3% | $59.1M | $15.0M | +294.7% |
| 2024-03-13 | $-0.29 | $-0.07 | -314.3% | $41.8M | $23.7M | +76.6% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 210.78M | 129.01M | 0 | 0 | 0 | 0 |
| Net Income | 65.63M | (6.68M) | (94.62M) | (51.16M) | (26.52M) | (4.65M) |
| EPS | 1.76 | -0.20 | -2.79 | -1.60 | -0.84 | -4.44 |
| Total Assets | 526.32M | 469.19M | 252.06M | 305.83M | 43.53M | 18.24M |
| Total Debt | 59.21M | 68.23M | 25.94M | 0 | 0 | 0 |
| Cash & Equivalents | 101.21M | 67.60M | 45.16M | 291.06M | 39.05M | 16.84M |
| Operating Cash Flow | (41.56M) | 139.80M | (93.79M) | (50.86M) | (25.57M) | (10.80M) |
| Free Cash Flow | (44.72M) | 134.19M | (96.67M) | (55.44M) | (27.89M) | (11.43M) |
| FCF per Share | -1.20 | 4.06 | -3.09 | -1.78 | -0.89 | -10.91 |
| Book Value | 428.68M | 242.36M | 212.55M | 298.72M | (41.49M) | (15.52M) |
| Cash & ST Investments | 420.00M | 351.97M | 188.71M | 291.06M | 39.05M | 16.84M |
| ROC Equity | 0.15 | -0.03 | -0.45 | -0.17 | N/A | N/A |